ストックスクリーナーアプリを入手
3.32
7.10%
0.22
プレマーケット:
3.29
-0.03
-0.90%
前日終値:
$3.10
開ける：
$3.09
24時間の取引高:
1.04M
Relative Volume:
0.40
時価総額：
$160.38M
収益：
-
当期純損益:
$-97.22M
株価収益率:
-2.4058
EPS:
-1.38
ネットキャッシュフロー:
$-82.44M
1週間 パフォーマンス:
-2.06%
1か月 パフォーマンス:
+12.16%
6か月 パフォーマンス:
+54.42%
1年 パフォーマンス:
+12.54%
1日の値動き範囲:
$3.06
$3.345
1週間の範囲:
$2.88
$3.44
52週間の値動き範囲:
$1.15
$4.98
Cassava Sciences Inc Stock (SAVA) Company Profile
名前
Cassava Sciences Inc
セクター
電話
512-501-2444
住所
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
SAVA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SAVA
Cassava Sciences Inc
|
3.32 | 149.75M | 0 | -97.22M | -82.44M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-26 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | 繰り返されました | Maxim Group | Buy |
| 2021-04-27 | 開始されました | B. Riley Securities | Buy |
| 2021-02-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-23 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-09-23 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-01-10 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Cassava Sciences Inc (SAVA) 最新ニュース
Can Cassava Sciences Inc. (PX91) stock deliver double digit returnsJuly 2025 Opening Moves & Reliable Price Action Trade Plans - Newser
What analysts say about Cassava Sciences Inc Equity Warrant stock - earlytimes.in
How Cassava Sciences Inc. Equity Warrant stock compares to industry benchmarksPortfolio Value Summary & AI Forecasted Entry and Exit Points - Newser
How Cassava Sciences Inc. (PX91) stock trades after rate cuts2025 Performance Recap & AI Powered Buy/Sell Recommendations - Newser
Cassava Sciences IncFDA requires additional information from Cassava for clinical studySEC filing - marketscreener.com
Cassava Says US FDA Seeks Additional Information for Simufilam IND Application for TSC-Related Epilepsy - MarketScreener
Cassava Sciences hit with FDA request for more data on simufilam trial (SAVA:NASDAQ) - Seeking Alpha
Cassava Sciences receives FDA request for more information on epilepsy trial - Investing.com
Cassava Sciences Submits IND Application for Simufilam - TipRanks
Cassava Sciences stock falls after FDA requests more data for epilepsy drug - Investing.com Canada
Does Cassava Sciences Inc. stock trade at a discount to peersAnalyst Downgrade & Weekly High Return Stock Forecasts - Newser
Cassava Sciences Receives FDA Request for Additional Information - TradingView
Will Cassava Sciences Inc. (PX91) stock beat Nasdaq index returnsJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Is Cassava Sciences Inc. stock a buy for dividend growthJuly 2025 Market Mood & Low Risk Investment Opportunities - Newser
Why Cassava Sciences Inc. Equity Warrant stock is rated strong buyTrade Performance Summary & Verified Chart Pattern Trade Signals - Newser
Published on: 2025-12-02 02:52:36 - Newser
Why Cassava Sciences Inc. (PX91) stock could be next leaderCEO Change & Consistent Profit Trade Alerts - Newser
Why Cassava Sciences Inc. (PX91) stock appeals to dividend investorsWeekly Profit Report & High Accuracy Swing Entry Alerts - Newser
How Cassava Sciences Inc. stock responds to policy changesJuly 2025 Patterns & Growth Oriented Trade Recommendations - BỘ NỘI VỤ
Can Cassava Sciences Inc. stock outperform in 2025 bull marketWeekly Trade Report & Free Weekly Watchlist of Top Performers - moha.gov.vn
Aug Sectors: What valuation multiples suggest for Cassava Sciences Inc. Equity Warrant stockDollar Strength & Real-Time Sentiment Analysis - BỘ NỘI VỤ
Dir Anderson Jr Buys 8,600 ($24.9K) Of Cassava Sciences Inc [SAVA] - TradingView
[Form 4] CASSAVA SCIENCES INC Insider Trading Activity - Stock Titan
Cassava Sciences rises 10% after market close on CEO stock buy - MSN
February 10, 2025 Deadline: Contact Levi & Korsinsky to Join Cla - GuruFocus
Down -39.52% in 4 Weeks, Here's Why Cassava Sciences (SAVA) Looks Ripe for a Turnaround - MSN
Cassava Sciences (NASDAQ:SAVA) CEO Purchases $201,808.75 in Stock - MarketBeat
Should You Invest in Dishman Carbogen Amcis Limited Before Its Next Earnings ReportEvening Star Patterns & Rapid Capital Portfolio - earlytimes.in
Cassava Sciences Sees Unusually High Options Volume (NASDAQ:SAVA) - MarketBeat
Cassava Sciences Stock Rise as CEO Makes Insider Purchase - Somos Hermanos -
Is Cassava Sciences Inc. stock attractive for retirement portfoliosGap Up & Safe Capital Allocation Plans - newser.com
Cassava Sciences stock up as CEO buys shares (SAVA:NASDAQ) - Seeking Alpha
Is Cassava Sciences Inc. stock attractive for income investorsMarket Trend Report & AI Enhanced Trading Signals - newser.com
Is Cassava Sciences Inc. stock a defensive play in 2025Market Performance Report & AI Powered Market Entry Strategies - newser.com
Why global investors buy Cassava Sciences Inc. (PX91) stockPortfolio Value Summary & Low Risk High Reward Trade Ideas - newser.com
Why Cassava Sciences Inc. Equity Warrant stock could be next big winnerPortfolio Profit Report & Real-Time Volume Trigger Notifications - newser.com
Can Cassava Sciences Inc. stock deliver consistent earnings growth2025 Volatility Report & Fast Entry High Yield Tips - newser.com
Why Cassava Sciences Inc. Equity Warrant stock is favored by top institutions2025 Key Highlights & Capital Protection Trading Alerts - newser.com
What momentum indicators show for Cassava Sciences Inc. stockGold Moves & Real-Time Chart Breakout Alerts - newser.com
Will Cassava Sciences Inc. Equity Warrant stock deliver shareholder value - newser.com
Will Cassava Sciences Inc. continue its uptrendMarket Performance Report & High Accuracy Investment Signals - newser.com
Cassava Sciences Inc (SAVA) 財務データ
収益
当期純利益
現金流量
EPS
1.10%
1.10%
大文字化:
|
ボリューム (24 時間):